Gareth W. John
Centre de Recherche Pierre Fabre
Castres Cedex
France
Name/email consistency: high
- KC 12291: an atypical sodium channel blocker with myocardial antiischemic properties. John, G.W., Létienne, R., Le Grand, B., Pignier, C., Vacher, B., Patoiseau, J.F., Colpaert, F.C., Coulombe, A. Cardiovasc. Drug. Rev (2004)
- F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine. John, G.W., Pauwels, P.J., Perez, M., Halazy, S., Le Grand, B., Verscheure, Y., Valentin, J.P., Palmier, C., Wurch, T., Chopin, P., Marien, M., Kleven, M.S., Koek, W., Assie, M.B., Carilla-Durand, E., Tarayre, J.P., Colpaert, F.C. J. Pharmacol. Exp. Ther. (1999)